Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding

Michelle Giles; Kumar Visvanathan; Joe Sasadeusz

doi:10.3851/IMP1813

Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding

Michelle Giles, Kumar Visvanathan, Joe Sasadeusz

Medicine Monash Health

Research output: Contribution to journal › Article › Research › peer-review

30 Citations (Scopus)

Abstract

It is estimated there are 350-400 million people worldwide chronically infected with HBV. Many of these are women and of reproductive age. As such, they may face therapeutic decisions regarding antiviral therapy and the implication this may have on future or current pregnancies. This article reviews the data of all antivirals licensed for use against hepatitis B infection regarding teratogenicity, carcinogenicity, clinical experience during pregnancy, placental transfer and excretion in breast milk.

Original language	English
Pages (from-to)	621 - 628
Number of pages	8
Journal	Antiviral Therapy
Volume	16
Issue number	5
DOIs	https://doi.org/10.3851/IMP1813
Publication status	Published - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3851/IMP1813

Cite this

@article{a6c8695822644abca80ea632d67c47bb,

title = "Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding",

abstract = "It is estimated there are 350-400 million people worldwide chronically infected with HBV. Many of these are women and of reproductive age. As such, they may face therapeutic decisions regarding antiviral therapy and the implication this may have on future or current pregnancies. This article reviews the data of all antivirals licensed for use against hepatitis B infection regarding teratogenicity, carcinogenicity, clinical experience during pregnancy, placental transfer and excretion in breast milk.",

author = "Michelle Giles and Kumar Visvanathan and Joe Sasadeusz",

year = "2011",

doi = "10.3851/IMP1813",

language = "English",

volume = "16",

pages = "621 -- 628",

journal = "Antiviral Therapy",

issn = "1359-6535",

publisher = "SAGE Publications Ltd",

number = "5",

}

TY - JOUR

T1 - Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding

AU - Giles, Michelle

AU - Visvanathan, Kumar

AU - Sasadeusz, Joe

PY - 2011

Y1 - 2011

N2 - It is estimated there are 350-400 million people worldwide chronically infected with HBV. Many of these are women and of reproductive age. As such, they may face therapeutic decisions regarding antiviral therapy and the implication this may have on future or current pregnancies. This article reviews the data of all antivirals licensed for use against hepatitis B infection regarding teratogenicity, carcinogenicity, clinical experience during pregnancy, placental transfer and excretion in breast milk.

AB - It is estimated there are 350-400 million people worldwide chronically infected with HBV. Many of these are women and of reproductive age. As such, they may face therapeutic decisions regarding antiviral therapy and the implication this may have on future or current pregnancies. This article reviews the data of all antivirals licensed for use against hepatitis B infection regarding teratogenicity, carcinogenicity, clinical experience during pregnancy, placental transfer and excretion in breast milk.

U2 - 10.3851/IMP1813

DO - 10.3851/IMP1813

M3 - Article

SN - 1359-6535

VL - 16

SP - 621

EP - 628

JO - Antiviral Therapy

JF - Antiviral Therapy

IS - 5

ER -